981 resultados para Epigrams, Latin.


Relevância:

70.00% 70.00%

Publicador:

Resumo:

v. 1. The Anglo-Latin satirical poets of the twelfth century.--v. 2. The minor Anglo-Latin satirists and epigrammatists.

Relevância:

70.00% 70.00%

Publicador:

Resumo:

Includes index.

Relevância:

70.00% 70.00%

Publicador:

Resumo:

v. 1. The Anglo-Latin satirical poets of the twelfth century.--v. 2. The minor Anglo-Latin satirists and epigrammatists.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Includes bibliographical references and indexes.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

No more published?

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Signatures: A-I¹² (-A¹²), K⁶.

Relevância:

60.00% 60.00%

Publicador:

Resumo:

Pars.1. Carmina in codicibus scripta, recensuit Alexander Riese. fasc.1. Libri Salmasiani aliorumque carmina.--fasc.2. Reliquorum librorum carmina.--Pars.2. Carmina epigraphica, conlegit Franciscus Buecheler. fasc.1-2. Carmina latina epigraphica.--fasc.3. Supplementum, curavit Ernestus Lommatzsch.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Four letters and epigrams dedicated to Catherine de Bauffremont. cf. p. 35.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

On verso of half-title: Paris, Imprimerie de Béthuine et Plon, rue de Vaugirard, 36.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Latin and English parallel text.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

This paper analyses how the topic of the silent statue is dealt with in Neo-Latin literature. The subject matter comes from the epigrams about Pythagoras of the Palatine Anthology. There are numerous Neo-Latin imitations of this topic that are complex as various sources are used at the same time. The authors focus on an active reading of the epigrams of their predecessors, applying the traditional motive to new subjects and adapting it to the religious theme.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

In this study, 103 unrelated South-American patients with mucopolysaccharidosis type II (MPS II) were investigated aiming at the identification of iduronate-2-sulfatase (IDS) disease causing mutations and the possibility of some insights on the genotype-phenotype correlation The strategy used for genotyping involved the identification of the previously reported inversion/disruption of the IDS gene by PCR and screening for other mutations by PCR/SSCP. The exons with altered mobility on SSCP were sequenced, as well as all the exons of patients with no SSCP alteration. By using this strategy, we were able to find the pathogenic mutation in all patients. Alterations such as inversion/disruption and partial/total deletions of the IDS gene were found in 20/103 (19%) patients. Small insertions/deletions/indels (<22 bp) and point mutations were identified in 83/103 (88%) patients, including 30 novel mutations; except for a higher frequency of small duplications in relation to small deletions, the frequencies of major and minor alterations found in our sample are in accordance with those described in the literature.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

There is a paucity of literature on haemophilia treatment in Latin American countries, a region characterized by rapidly improving systems of care, but with substantial disparities in treatment between countries. The aim of this study was to evaluate the musculoskeletal status of haemophilia patients from Latin America and to examine the relationship between musculoskeletal status and treatment practices across countries. The Committee of Latin America on the Therapeutics of Inhibitor Groups conducted a survey of its member country representatives on key aspects of haemophilia treatment in 10 countries. Musculoskeletal status of patients was obtained during routine comprehensive evaluations between March 2009 and March 2011. Eligible patients had severe haemophilia A (factor VIII <1%) without inhibitors (<0.6 BU mL(-1) ) and were ≥5 years of age. Musculoskeletal status was compared between three groups of countries, based primarily on differences in the availability of long-term prophylaxis. Overall, 143 patients (5-66 years of age) were enrolled from nine countries. In countries where long-term prophylaxis had been available for at least 10 years (Group A), patients aged 5-10 years had significantly better mean World Federation of Hemophilia clinical scores, fewer target joints and fewer affected joints than patients from countries where long-term prophylaxis has been available for about 5 years (Group B) or was not available (Group C). In Latin America, the musculoskeletal status of patients with severe haemophilia without inhibitors has improved significantly in association with the provision of long-term prophylaxis. As more countries in Latin America institute this practice, further improvements are anticipated.